Your browser doesn't support javascript.
loading
A core outcome set for trials evaluating self-management interventions in people with severe mental illness and coexisting type 2 diabetes.
Carswell, Claire; Taylor, Jo; Holt, Richard I G; Brown, Jennifer V E; Ajjan, Ramzi; Böhnke, Jan R; Doran, Tim; Kellar, Ian; Shiers, David; Wright, Judy; Siddiqi, Najma.
Afiliación
  • Carswell C; Department of Health Sciences, University of York, York, UK.
  • Taylor J; Department of Health Sciences, University of York, York, UK.
  • Holt RIG; Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Brown JVE; National Institute for Health Research Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Ajjan R; Department of Health Sciences, University of York, York, UK.
  • Böhnke JR; Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
  • Doran T; School of Health Sciences, University of Dundee, Dundee, UK.
  • Kellar I; Department of Health Sciences, University of York, York, UK.
  • Shiers D; Department of Psychology, University of Sheffield, Sheffield, UK.
  • Wright J; Psychosis Research Unit, Greater Manchester Mental Health NHS Trust, Manchester, UK.
  • Siddiqi N; Division of Psychology and Mental Health, University of Manchester, Manchester, UK.
Diabet Med ; 41(4): e15288, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38239101
ABSTRACT

BACKGROUND:

People with severe mental illness (SMI), such as schizophrenia, have higher rates of type 2 diabetes and worse outcomes, compared to those without SMI and it is not known whether diabetes self-management interventions are effective for people who have both conditions. Research in this area has been impeded by a lack of consensus on which outcomes to prioritise in people with co-existing SMI and diabetes.

AIMS:

To develop a core outcome set (COS) for use in effectiveness trials of diabetes self-management interventions in adults with both type 2 diabetes and SMI.

METHODS:

The COS was developed in three stages (i) identification of outcomes from systematic literature review of intervention studies, followed by multi-stakeholder and service user workshops; (ii) rating of outcomes in a two-round online Delphi survey; (iii) agreement of final 'core' outcomes through a stakeholder consensus workshop.

RESULTS:

Seven outcomes were selected glucose control, blood pressure, body composition (body weight, BMI, body fat), health-related quality of life, diabetes self-management, diabetes-related distress and medication adherence.

CONCLUSIONS:

This COS is recommended for future trials of effectiveness of diabetes self-management interventions for people with SMI and type 2 diabetes. Its use will ensure trials capture important outcomes and reduce heterogeneity so findings can be readily synthesised to inform practice and policy.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Automanejo / Trastornos Mentales Tipo de estudio: Prognostic_studies Límite: Humans / Male Idioma: En Revista: Diabet Med Asunto de la revista: ENDOCRINOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Automanejo / Trastornos Mentales Tipo de estudio: Prognostic_studies Límite: Humans / Male Idioma: En Revista: Diabet Med Asunto de la revista: ENDOCRINOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido